4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-15-081865
COO, CLO, and Secretary sold 153,333 shares at $12.84 ($1,968,796)
- COO, CLO, and Secretary acquired 153,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BELBEL CAESAR J COO, CLO, and Secretary | 2015-11-19 | Option exercise | +153,333 | $2.30 | $352,666 | 212,534 | D |
| BELBEL CAESAR J COO, CLO, and Secretary | 2015-11-19 | Sale | −153,333 | $12.84 | $1,968,796 | 59,201 | D |
| Derivatives | |||||||
| BELBEL CAESAR J COO, CLO, and Secretary | 2015-11-19 | Option exercise · Stock Option (right to buy) | −153,333 | 76,667 | D | ||
| Open-market sales · 153,333 sh · avg $12.84 · $1,968,796 | |||||||
Loading xslF345X03/doc4.xml…